Brownlee W, et al. Early focal inflammatory disease is associated with long-term cognitive performance in relapse-onset multiple sclerosis. ECTRIMS 2018, abstract 97.
Extra voordeel langere dosisinterval natalizumab: minder JCV-conversie
mei 2025 | Multipele Sclerose